Between 19th and 20th of May the IMAGO-MOL Cluster participated in the VELES Consortium Meeting held in Valencia, Spain, bringing together project partners to review achievements to date and shape the roadmap for the next phases of implementation.
Over the course of two productive days, consortium members assessed the project’s progress and discussed upcoming activities, benefiting from insightful presentations delivered by VELES researchers and representatives of the Valencian innovation ecosystem, including Universitat Politècnica de València (UPV) and valgrAI.
A key highlight of the meeting was the presentation delivered by IMAGO-MOL Cluster representatives, Catalin Mironeanu and Corina Morosan, who addressed important aspects related to GDPR compliance and data governance within the cerebral tumours pilot. Their contribution was highly appreciated by consortium partners for its relevance and practical insights into responsible data management in health research.
The meeting also provided valuable opportunities for knowledge exchange, collaboration, and networking among partners, fostering stronger cooperation toward the development of innovative digital health solutions and data-driven healthcare initiatives.
Special thanks go to Inneürope for their warm hospitality and excellent organization of the event, creating an inspiring environment for productive discussions, collaboration, and the advancement of the VELES project objectives.
The VELES Consortium brings together leading European organizations, including IMAGO-MOL Cluster, GATE Institute, JOIST, Telelink Business Services, Hellenic Digital Health Cluster (HDHC), National eHealth Authority Cyprus, UEFISCDI, Chalmers Industriteknik, CYENS Centre of Excellence, Ministry of Electronic Governance Bulgaria, AMEN, 3aHealth, Health and Life Sciences Cluster Bulgaria – BioCluster.bg, International Data Spaces Association (IDSA), and Inneürope, all working together to strengthen a European innovation ecosystem powered by data and artificial intelligence in healthcare.







